Virginia Commonwealth University: Leukemia trials
The registry lists 16 Leukemia studies with Virginia Commonwealth University as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 8Phase 2 5Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant RecipientsCompletedNCT03613727Phase 2Results posted
- Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD ProphylaxisCompletedNCT02593123Phase 2Results posted
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCTCompletedNCT00709592Phase 2Results posted
- Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT03964259Phase 1
- Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLLWithdrawnNCT03639324Phase 1
- Effect of Prevention Education in Caries Formation in Pediatric Patients With LeukemiaTerminatedNCT03281746Not applicable
- Physical Activity as Self-Management Approach to Improve Health Outcomes in AMLCompletedNCT02584296Not applicable
- Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain TumorsWithdrawnNCT02000986Not applicable
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic SyndromeCompletedNCT01075425Phase 1
- Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00963274Phase 1
- Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic CancerCompletedNCT00064285Phase 1
- Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00017342Phase 2
- Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00005580Phase 1
- Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic LymphomaCompletedNCT00003187Phase 2/3
- Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or LymphomaCompletedNCT00003079Phase 1
- High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesCompletedNCT00002818Phase 1